Yatsen turns to AI and biotech as demand grows for targeted beauty products
The company is using technology for things like new ingredient discovery as Chinese consumers seek increasingly…
China’s hepatitis B drug race enters critical phase as Cosunter commits 587 million yuan
The Chinese drugmaker is stepping up investment in its hepatitis B pipeline as GSK’s bepirovirsen wins regulatory…
Chinese innovative drug makers step onto the global stage through licensing and foreign co-co deals
By Da Cheung In 2025, China’s innovative pharmaceutical companies quietly crossed a historic threshold, overtaking the…
China’s AI drug-discovery champion sees survival as the biggest challenge
By Chen Guangjing Do China’s AI drug discovery champions need to worry about survival? For Wen…
Biotech startup METiS Therapeutics plans Hong Kong IPO with AI-driven drug delivery revolution
By Da Cheung METiS Therapeutics, a drug discovery and delivery biotech, has received the regulatory green light…
Latest
- After forced Meta split, AI startup Manus regroups with new $500 million funding
- China’s maturing energy storage sector creates giants, leaves behind trail of bankruptcies
- A Guangzhou factory bet big on robots. Its customers only wanted them to carry more.
- China’s satellite IoT bet: small data, big business
- Tactile sensor maker Tashan targets IPO after completing share reform
